CoronaVR
Image


Predicted highly potential T-cell epitopes (CD8)



No Protein Epitope sequence Start Stop Length Conservancy
1 M RINWITGGIA 72 81 10 90% (SARS-CoV)
2 M VYRINWITGG 70 79 10 90% (SARS-CoV)
3 NSP3 DCEEEEFEPS 935 944 10 50% (SARS-CoV), 505 (MERS-CoV), 50% (OC43)
4 NSP2 EHEHEIAWYT 233 242 10 80% (SARS-CoV)
5 NSP3 GDCEEEEFEP 934 943 10 50% (SARS-CoV), 50% (MERS-CoV)
6 2'-O-ribose methyltransferase (NSP16) GHFAWWTAF 6983 6991 9 88.89% (SARS-CoV)
7 2'-O-ribose methyltransferase (NSP16) GHFAWWTAFV 6983 6992 10 90% (SARS-CoV)
8 2'-O-ribose methyltransferase (NSP16) HFAWWTAFV 6984 6992 9 88.89% (SARS-CoV)
9 NSP2 KLNEEIAIIL 468 477 10 80% (SARS-CoV)
10 NSP2 LNEEIAIILA 469 478 10 90% (SARS-CoV)
11 NSP4 LVPFWITIA 3135 3143 9 66.67% (SARS-CoV)
12 NSP4 LVPFWITIAY 3135 3144 10 70% (SARS-CoV)
13 2'-O-ribose methyltransferase (NSP16) MGHFAWWTA 6982 6990 9 88.89% (SARS-CoV)
14 2'-O-ribose methyltransferase (NSP16) MGHFAWWTAF 6982 6991 10 90% (SARS-CoV), 90% (MERS-CoV)
15 NSP4 PLVPFWITIA 3134 3143 10 70% (SARS-CoV)
16 NSP4 TKHFYWFFS 3150 3158 9 55.56% (SARS-CoV)
17 NSP4 VPFWITIAY 3136 3144 9 77.78% (SARS-COV)
18 NSP4 VPFWITIAYI 3136 3145 10 70% (SARS-CoV)
19 S NVTWFHAIHV 61 70 10 60% (SARS-CoV)
20 ORF7b IMLIIFWFSL 23 32 10 100% (SARS-CoV)
21 ORF7b MLIIFWFSL 24 32 9 100% (SARS-CoV)